Fideuram Asset Management Ireland dac Acquires New Holdings in Elevance Health, Inc. $ELV

Fideuram Asset Management Ireland dac acquired a new stake in shares of Elevance Health, Inc. (NYSE:ELV) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,543 shares of the company’s stock, valued at approximately $891,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. National Pension Service raised its position in Elevance Health by 5.5% in the fourth quarter. National Pension Service now owns 580,727 shares of the company’s stock worth $203,574,000 after acquiring an additional 30,530 shares during the period. SBI Okasan Asset Management Co.Ltd. bought a new position in Elevance Health in the fourth quarter worth approximately $1,428,000. Foundations Investment Advisors LLC raised its position in Elevance Health by 5.9% in the fourth quarter. Foundations Investment Advisors LLC now owns 2,843 shares of the company’s stock worth $997,000 after acquiring an additional 159 shares during the period. Thoroughbred Financial Services LLC bought a new position in Elevance Health in the fourth quarter worth approximately $297,000. Finally, Syverson Strege & Co raised its position in Elevance Health by 9.4% in the fourth quarter. Syverson Strege & Co now owns 734 shares of the company’s stock worth $257,000 after acquiring an additional 63 shares during the period. Institutional investors own 89.24% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on ELV. Weiss Ratings upgraded shares of Elevance Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, May 18th. Bank of America upgraded shares of Elevance Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $405.00 to $435.00 in a research report on Wednesday, April 29th. Wall Street Zen downgraded shares of Elevance Health from a “buy” rating to a “hold” rating in a research report on Sunday, February 8th. The Goldman Sachs Group increased their price target on shares of Elevance Health from $350.00 to $370.00 and gave the stock a “neutral” rating in a research report on Friday, April 24th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Elevance Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $363.00 to $498.00 in a research report on Wednesday, May 20th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $403.11.

Elevance Health Stock Performance

ELV opened at $394.40 on Friday. The stock has a market capitalization of $85.65 billion, a price-to-earnings ratio of 16.78, a PEG ratio of 2.22 and a beta of 0.66. The company has a fifty day moving average of $343.75 and a 200 day moving average of $338.90. Elevance Health, Inc. has a fifty-two week low of $273.71 and a fifty-two week high of $408.00. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.48 and a current ratio of 1.48.

Elevance Health (NYSE:ELV) last posted its earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share for the quarter, beating the consensus estimate of $10.74 by $1.84. The company had revenue of $49.49 billion during the quarter, compared to analysts’ expectations of $48.21 billion. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. Elevance Health’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period last year, the company posted $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. As a group, sell-side analysts forecast that Elevance Health, Inc. will post 26.94 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be paid a dividend of $1.72 per share. This represents a $6.88 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Wednesday, June 10th. Elevance Health’s dividend payout ratio (DPR) is presently 29.26%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.